Work

No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: Results of two randomized, double-blind, placebo-controlled clinical trials

Year: 2000

Type: article

Study design: Clinical Trial

Source: Annals of Neurology

DOI: 10.1002/1531-8249(200002)47:2<238::aid-ana15>3.0.co;2-l

Authors: K. I. Roon, J. Olesen, H. C. Diener, P. Ellis, J. Hettiarachchi, P. H. Poole, I. Christianssen, D. Kleinermans, J. G. Kok, M. D. Ferrari

Institutions: Leiden University, Leiden University Medical Center, Glostrup Hospital, Essen University Hospital, Pfizer (United Kingdom), Erasmus Hospital, Pfizer (Belgium)

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2143111363

FWCI: 5.36

Cites: 10

Cited by: 91

Related to: 10